PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

286 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... 11 ... 12 ... 13 ... 14 ... 15 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
41.
Maalmi, H.* et al.: Serum neurofilament light chain: A novel biomarker for early diabetic sensorimotor polyneuropathy. Diabetologia 66, 579-589 (2022)
42.
Meyhöfer, S.* et al.: Sleep deprivation prevents counterregulatory adaptation to recurrent hypoglycaemia. Diabetologia 65, 1212-1221 (2022)
43.
Morgenstern, J.* et al.: Correction to: Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy. Diabetologia 65:257 (2022)
44.
Ng, K.* et al.: Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children. Diabetologia 66, 93-104 (2022)
45.
Sola-Gazagnes, A.* et al.: Insulin allergy: A diagnostic and therapeutic strategy based on a retrospective cohort and a case–control study. Diabetologia 65, 1278-1290 (2022)
46.
Weiss, A. et al.: Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening. Diabetologia 65, 93-104 (2022)
47.
Weiss, A. et al.: Correction to: Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening. Diabetologia, DOI: 10.1007/s00125-022-05798-z (2022)
48.
Woelfle, T.* et al.: Health impact of seven herpesviruses on (pre)diabetes incidence and HbA1c: Results from the KORA cohort. Diabetologia 65, 1328-1338 (2022)
49.
Assfalg, R. et al.: Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial. Diabetologia 64, 1079-1092 (2021)
50.
Bediaga, N.G.* et al.: Simplifying prediction of disease progression in pre-symptomatic type 1 diabetes using a single blood sample. Diabetologia, DOI: 10.1007/s00125-021-05523-2 (2021)
51.
Gar, C. et al.: The liver–alpha cell axis associates with liver fat and insulin resistance: A validation study in women with non-steatotic liver fat levels. Diabetologia 64, 512-520 (2021)
52.
Gastaldelli, A.* ; Stefan, N. & Häring, H.-U.: Liver-targeting drugs and their effect on blood glucose and hepatic lipids. Diabetologia 64, 1461-1479 (2021)
53.
Gerst, F. et al.: The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells. Diabetologia 64, 1358–1374 (2021)
54.
Giroud, M. et al.: HAND2 is a novel obesity-linked adipogenic transcription factor regulated by glucocorticoid signalling. Diabetologia 64, 1850-1865 (2021)
55.
Johnson, R.K.* et al.: Maternal food consumption during late pregnancy and offspring risk of islet autoimmunity and type 1 diabetes. Diabetologia 64, 1604-1612 (2021)
56.
Johnson, S.B.* et al.: First-appearing islet autoantibodies for type 1 diabetes in young children: Maternal life events during pregnancy and the child’s genetic risk. Diabetologia 64, 591-602 (2021)
57.
Krischer, J.P.* et al.: Characteristics of children diagnosed with type 1 diabetes before vs after 6 years of age in the TEDDY cohort study. Diabetologia 64, 2247-2257 (2021)
58.
Morgenstern, J.* et al.: Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy. Diabetologia, DOI: 10.1007/s00125-021-05557-6 (2021)
59.
Pistrosch, F.* et al.: Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: A randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers. Diabetologia, DOI: 10.1007/s00125-021-05562-9 (2021)
60.
Achenbach, P. et al.: Heterogeneous islet autoantibody evolution trajectories in multi-site birth cohort studies. Diabetologia 63, 1, S160-S160 (2020)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... 11 ... 12 ... 13 ... 14 ... 15 ... ▶▶ ▶▮